Ensign Peak Advisors’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-21,490
| Closed | -$207K | – | 1870 |
|
|
2022
Q3 | $207K | Buy |
21,490
+1,390
| +7% | +$13.4K | ﹤0.01% | 1861 |
|
|
2022
Q2 | $146K | Hold |
20,100
| – | – | ﹤0.01% | 1887 |
|
|
2022
Q1 | $259K | Hold |
20,100
| – | – | ﹤0.01% | 1802 |
|
|
2021
Q4 | $321K | Hold |
20,100
| – | – | ﹤0.01% | 1792 |
|
|
2021
Q3 | $323K | Buy |
20,100
+6,500
| +48% | +$104K | ﹤0.01% | 1699 |
|
|
2021
Q2 | $188K | Buy |
13,600
+2,000
| +17% | +$27.6K | ﹤0.01% | 1728 |
|
|
2021
Q1 | $169K | Hold |
11,600
| – | – | ﹤0.01% | 1743 |
|
|
2020
Q4 | $202K | Buy |
+11,600
| New | +$202K | ﹤0.01% | 1722 |
|
|
2020
Q2 | – | Sell |
-3,457
| Closed | -$56K | – | 1677 |
|
|
2020
Q1 | $56K | Sell |
3,457
-14,277
| -81% | -$231K | ﹤0.01% | 1601 |
|
|
2019
Q4 | $319K | Buy |
+17,734
| New | +$319K | ﹤0.01% | 1584 |
|